Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Sanofi Rilzabrutinib earns orphan designation in EU for IgG4 related disease

Sanofi gets CDSCO marketing nod for RSV treatment Beyfortus in India

Ruchika Sharma1 Aug 2024 5:30 PM IST

Drugmaker, Sanofi India, has received marketing authorisation approval from the Central Drugs Standard Control Organisation (CDSCO) for Beyfortus in...

Shilpa Medicare arm partners with Orion Corporation for Recombinant Human Albumin for European Market

Shilpa Pharma Lifesciences receives certificate of suitability from EDQM for Ursodeoxycholic Acid

Ruchika Sharma1 Aug 2024 2:26 PM IST

Karnataka: Shilpa Medicare Limited's 100 percent subsidiary, Shilpa Pharma Lifesciences Limited has received certificate of suitability (CEP)...

Natco Pharma Independent Director Dr MUR Naidu no more

Ruchika Sharma1 Aug 2024 12:28 PM IST

Telangana: Natco Pharma has announced the sad demise of Dr M.U.R. Naidu, Independent Director of the Company on 30th July, 2024.Dr. M.U.R....

Zydus, Synthon enters into licensing, supply agreement for multiple sclerosis drug Ozanimod for US

Zydus Lifesciences gets Mexican marketing approval for Mamitra to treat various cancers \

Ruchika Sharma1 Aug 2024 11:46 AM IST

Ahmedabad: Zydus Lifesciences Limited has announced that the Mexican regulatory authority COFEPRIS (Federal Commission for the Protection...

Bayer submits New Drug Application to USFDA for Elinzanetant for treatment of moderate to severe vasomotor symptoms associated with menopause

Ruchika Sharma1 Aug 2024 10:00 AM IST

Berlin: Bayer has announced that a New Drug Application (NDA) for the investigational compound elinzanetant has been submitted to the U.S. Food...

Duchenne muscular dystrophy: Sanofi owned biotech company sues Sarepta Therapeutics over patent infringement

Ruchika Sharma31 July 2024 4:02 PM IST

Sanofi-owned biotech company Genzyme has initiated a lawsuit against competitor Sarepta Therapeutics in Delaware federal court, accusing the firm of...

Alembic Pharma wins USFDA approval for pulmonary arterial hypertension drug Macitentan

Lupin bags tentative USFDA nod for HIV-1 infection drugs

Ruchika Sharma31 July 2024 12:30 PM IST

Mumbai: Global pharma major Lupin Limited today announced that it has received tentative approval from the United States Food and Drug...

WHO unveils new guideline to improve global access to controlled medicines

Biological E gets WHO pre-qualification status for oral polio vaccine

Ruchika Sharma31 July 2024 11:38 AM IST

Hyderabad: In a stride towards eradicating polio worldwide, Biological E. Limited (BE), a Hyderabad-based vaccine and pharmaceutical company has...

Himachal to develop medical device park independently

Himachal to develop Nalagarh Medical Park with state resources, returns Central Rs 30 Crore

Ruchika Sharma30 July 2024 5:23 PM IST

Shimla: Prioritizing state interests, the Himachal Pradesh government has decided to independently build a medical device park in Nalagarh, Solan...

Strides Pharma Science arm voluntarily dissolves

Strides Pharma Q1 results: Net profit at Rs 84 crore vs net loss of Rs 29.5 crore a year ago

Ruchika Sharma30 July 2024 4:24 PM IST

Bangalore: Strides Pharma Science has announced a profit after tax (PAT) from continuing operations of Rs 84 crore for the first quarter ended...

Cipla arm Medispray Goa facility classified as VAI by USFDA

Cipla to begin supplies from China facility to US later this year

Ruchika Sharma30 July 2024 12:35 PM IST

Pharmaceutical giant Cipla expects to begin supplies from its China-based facility to the US market in the latter half of the current fiscal year,...

Dr Reddys Labs API Mirfield facility gets 7 USFDA observations

Dr Reddy's Labs reports marginal decline in profit in Q1

Ruchika Sharma30 July 2024 10:30 AM IST

New Delhi: Dr Reddy's Laboratories reported a marginal decline in its consolidated profit after tax (PAT) for the first quarter ending June 30,...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok